TrialClinical cardiology2019

Eplerenone in patients with myocardial infarction and "mid-range" ejection fraction: An analysis from the EPHESUS trial.

João Pedro Ferreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.